UCB, Inc.
UCB, Inc.
1950 Lake Park Drive
Smyrna, Georgia 30080
Phone: (770) 970-7500Website: https://www.ucb-usa.com/Careers: careers.ucb.comPatient Assistance Program: www.ucb-usa.com/Patients/Patients
Latest news
- UCB Receives U.S. FDA Approval for Bimzelx (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate to Severe Hidradenitis Suppurativa
20 November 2024 - UCB Receives U.S. FDA Approval for 320 mg Single-Injection Device Presentations of Bimzelx (bimekizumab-bkzx)
14 October 2024 - UCB Announces U.S. FDA Approvals for Bimzelx (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis
23 September 2024 - FDA Approves Bimzelx (bimekizumab-bkzx) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis
18 October 2023 - FDA Approves Zilbrysq (zilucoplan) for the Treatment of Adults with Generalized Myasthenia Gravis
17 October 2023 - UCB Provides Update on U.S. Regulatory Review of Bimekizumab
19 September 2023 - FDA Approves Rystiggo (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis
27 June 2023 - UCB Provides Update on U.S. FDA Review of the Biologics License Application for Bimekizumab
26 June 2023 - UCB Announces Rozanolixizumab BLA for the Treatment of Generalized Myasthenia Gravis Filed with U.S. FDA and Designated for Priority Review
6 January 2023 - UCB Announces U.S. FDA Acceptance of New Drug Application and EMA MAA Validation for Zilucoplan for the Treatment of Generalized Myasthenia Gravis in Adult Patients
14 November 2022
Drugs Associated with UCB, Inc.
UCB, Inc. manufactures, markets and/or distributes more than 11 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Bimzelx
Generic name: bimekizumab Drug class: interleukin inhibitors |
11 reviews | 9.1 / 10 |
|
Briviact
Generic name: brivaracetam Drug class: pyrrolidine anticonvulsants |
58 reviews | 6.5 / 10 |
|
Cimzia
Generic name: certolizumab Drug class: TNF alfa inhibitors |
87 reviews | 6.7 / 10 |
|
Fintepla
Generic name: fenfluramine Drug class: CNS stimulants, miscellaneous anticonvulsants |
||
|
Keppra
Generic name: levetiracetam Drug class: pyrrolidine anticonvulsants |
283 reviews | 5.7 / 10 |
|
Keppra XR
Generic name: levetiracetam Drug class: pyrrolidine anticonvulsants |
17 reviews | 7.1 / 10 |
|
Nayzilam
Generic name: midazolam Drug class: benzodiazepines |
6 reviews | 9.7 / 10 |
|
Neupro
Generic name: rotigotine Drug class: dopaminergic antiparkinsonism agents |
67 reviews | 7.7 / 10 |
|
Rystiggo
Generic name: rozanolixizumab Drug class: selective immunosuppressants |
2 reviews | 8.0 / 10 |
|
Vimpat
Generic name: lacosamide Drug class: miscellaneous anticonvulsants |
150 reviews | 6.8 / 10 |
|
Zilbrysq
Generic name: zilucoplan Drug class: selective immunosuppressants |
2 reviews | 9.0 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||